-+ 0.00%
-+ 0.00%
-+ 0.00%

Relmada Therapeutics Form4 Filing Shows CEO Sergio Traversa Bought 1,225,500 Shares At An Average Price Of $0.09/Share

Benzinga·12/16/2025 14:33:19
語音播報

- SEC Filing